Markets:

Overview

News

Currencies

International

Treasuries

23andMe Holding Co. - Common Stock (NQ:ME)

0.6063 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 23andMe Holding Co. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

I Bought 2 SPACs That Haven't Lived Up to Expectations -- Here's Why I'm Still Holding Them ↗

October 28, 2022

These companies haven't performed as well as I thought they would, but I don't plan to sell.

Via The Motley Fool

23andMe Granted New FDA Clearance to Provide Interpretive Drug Information for a Commonly Prescribed Cholesterol Medication

October 27, 2022

FDA 510(k) clearance allows 23andMe to report genetics associated with processing of certain statins, provides interpretive drug information for simvastatin, and removes the requirement for...

From 23andMe Holding Co.

Via GlobeNewswire

23andMe to Report FY2023 Second Quarter Financial Results

October 24, 2022

From 23andMe Holding Co.

Via GlobeNewswire

CFO Transition Rocks 23andMe (ME) Stock ↗

August 19, 2022

23andMe's CFO, Steven Schoch, is stepping down. But ME stock's fall today likely has more to do with broader market forces.

Via InvestorPlace

Bill Gates, Warren Buffett's Initiative For Billionaires To Donate Most Of Their Wealth Sees Sharp Drop In Pledgers In 2022 ↗

October 24, 2022

“Giving Pledge” foundation — started by billionaires Bill Gates and Warren Buffett — has seen pledging commitments drop steeply this year, which has been marred by g

Via Benzinga

2 Budding Growth Stocks That Could Turn $1,000 Into $10,000 in 8 Years ↗

October 21, 2022

They're both using unique and highly efficient approaches to developing and deploying their medicines.

Via The Motley Fool

23andMe to Present at Upcoming Investor Conferences

October 12, 2022

From 23andMe Holding Co.

Via GlobeNewswire

23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting

October 05, 2022

Poster to provide details on study design and expansion phase for ongoing Phase 1 study in patients with advanced solid malignancies

From 23andMe Holding Co.

Via GlobeNewswire

7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On ↗

September 28, 2022

Reddit stocks had a bad name once, but over time, Reddit has become a more reliable bellwether for stocks to buy in the short term.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022 ↗

September 22, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 19, 2022

Via Benzinga

Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday ↗

August 22, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.

Via Benzinga

Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session ↗

August 19, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.

Via Benzinga

What Is Going on With Madison Square Garden (MSGE) Stock Today? ↗

August 19, 2022

Madison Square Garden (MSGE) stock is getting a boost on Friday following approval from its Board to explore a potential spin-off.

Via InvestorPlace

The Hidden Reason MindMed (MNMD) Stock Is Still Climbing ↗

August 19, 2022

MindMed (MNMD) stock is a hot topic on Friday as the company's shares continue to rally with investors seeing it as a short-squeeze target.

Via InvestorPlace

AppLovin, Unity Software And Some Other Big Losers From Monday ↗

August 16, 2022

U.S. stocks closed higher on Monday, with the Dow Jones gaining around 150 points. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗

August 16, 2022

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

Via Benzinga

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session ↗

August 15, 2022

Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...

Via Benzinga

Li Auto And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

August 15, 2022

Turquoise Hill Resources Ltd. (NYSE: TRQ) shares fell 18.1% to $21.50 in pre-market trading after the company’s special committee rejected Rio Tinto’s offer worth $2.7 billion for the rest 49% stake in...

Via Benzinga

Why Is Turquoise Hill Resources Down By 18%: Here Are 31 Stocks Moving Premarket ↗

August 15, 2022

Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented positive data from ongoing ReSPECT™ clinical trials at the Annual Conference...

Via Benzinga

LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday ↗

August 12, 2022

WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests...

Via Benzinga

What Is Going on With 23andMe (ME) Stock Today? ↗

August 11, 2022

23andMe, Invitae and others are seeing an explosive rally, but investors want to know if ME stock and others can continue to climb.

Via InvestorPlace

Why Jim Cramer Is Avoiding This Entire Group Of Stocks: 'They Break Your Heart Too Many Times' ↗

August 10, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said JPMorgan Chase & Co is starting to move higher. Cramer said 23andMe Holding Co (NASDAQ: ME) has "no mojo. That’s a technical term for 'not going...

Via Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗

August 09, 2022

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket ↗

August 09, 2022

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.

Via Benzinga

23andMe to Report FY2023 First Quarter Financial Results

July 25, 2022

From 23andMe Holding Co.

Via GlobeNewswire

Jim Cramer Is Shocked This Stock Is At $2: 'I Think That The Risk Is Priced In' ↗

July 12, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is shocked to see 23andMe Holding Co. (NASDAQ: ME) at $2. "At $2, I think that the risk is priced in," he added.

Via Benzinga

Worst Performing SPACs: Are They Dead or Will They Rebound? ↗

July 03, 2022

Here are 20 SPACs with truly dreadful performance.

Via Talk Markets

7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On ↗

June 30, 2022

Reddit stocks had a bad name once, but over time, Reddit has become a more reliable bellwether for stocks to buy in the short term.

Via InvestorPlace

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.